연구동향
기준 논문: Clinical Data Interchange Standards in Clinical Trials on Alzheimer's Disease
이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.
1,613편 검색→1,574편 판독→170편 선별 (관련도 0.5 이상)
질문과 PubMed 검색식 보기
질문: Data standards in Alzheimer disease trials
Data standards in Alzheimer disease trials출판 연도
선별된 170편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.
주제별 논문
주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.
01drug · development49편
- 0.90
Development of a unified clinical trial database for Alzheimer's disease
Neville J, Kopko S, Broadbent S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015
- 0.88
Doherty LK, Dechiario I, Sherif H et al. · Neuroepidemiology · 2026
- 0.86
Accelerating drug development for Alzheimer's disease through the use of data standards
Neville J, Kopko S, Romero K et al. · Alzheimer's & dementia (New York, N. Y.) · 2017
- 0.86
Alzheimer's clinical research data via R packages: The alzverse
Donohue MC, Hussen K, Langford O et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
- 0.85
Estimating Socio-Economic Status for Alzheimer's Disease Trials
Rentz DM, Grill JD, Molina-Henry DP et al. · The journal of prevention of Alzheimer's disease · 2024
- 0.84
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols
Wilcock D, Jicha G, Blacker D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
- 0.82
Artificial intelligence-enabled safety monitoring in Alzheimer's disease clinical trials
Jimenez-Maggiora GA, Donohue MC, Rafii MS et al. · The journal of prevention of Alzheimer's disease · 2025
- 0.81
The Data Gap in the EHR for Clinical Research Eligibility Screening
Butler A, Wei W, Yuan C et al. · AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2018
- 0.81
Lyketsos CG, Roberts SB, Swift EK et al. · The journal of prevention of Alzheimer's disease · 2022
- 0.76
Berres M, Monsch AU, Spiegel R · Alzheimer's research & therapy · 2021
- 0.73
Worldwide Alzheimer's disease neuroimaging initiative
Carrillo MC, Bain LJ, Frisoni GB et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2012
- 0.72
Galvin JE, Cummings JL, Benea ML et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
- 0.71
The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update
Hendrix JA, Finger B, Weiner MW et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015
- 0.71
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
Weiner MW, Veitch DP, Aisen PS et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015
- 0.71
Impact of non-binding FDA guidances on primary endpoint selection in Alzheimer's disease trials
Yu JC, Hlavka JP, Joe E et al. · Alzheimer's & dementia (New York, N. Y.) · 2022
- 0.70
Kornhuber J, Schmidtke K, Frolich L et al. · Dementia and geriatric cognitive disorders · 2009
- 0.68
Sadarangani T, Anderson K, Westmore MR et al. · Alzheimer's & dementia (New York, N. Y.) · 2022
- 0.67
Improving data sharing in research with context-free encoded missing data
Hoevenaar-Blom MP, Guillemont J, Ngandu T et al. · PloS one · 2017
- 0.66
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives
Weber CJ, Carrillo MC, Jagust W et al. · Alzheimer's & dementia (New York, N. Y.) · 2021
- 0.66
MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols
Lu H, Kashani AH, Arfanakis K et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
- 0.66
Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP Project
Gallacher J, de Reydet de Vulpillieres F, Amzal B et al. · Journal of Alzheimer's disease : JAD · 2019
- 0.65
Antuono P, Doody R, Gilman S et al. · Alzheimer disease and associated disorders · 1997
- 0.64
Study design considerations: conducting global clinical trials in early Alzheimer's disease
Schindler RJ · The journal of nutrition, health & aging · 2010
- 0.63
Jack CRJ, Barkhof F, Bernstein MA et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2011
- 0.63
Overcoming challenges to data quality in the ASPREE clinical trial
Lockery JE, Collyer TA, Reid CM et al. · Trials · 2019
- 0.63
Duchesne S, Collins DL, Barlow L et al. · The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2024
- 0.62
Imago Mundi, Imago AD, Imago ADNI
Villemagne VL, Kim SY, Rowe CC et al. · Alzheimer's research & therapy · 2014
- 0.62
Evans S, McRae-McKee K, Hadjichrysanthou C et al. · Alzheimer's & dementia (New York, N. Y.) · 2019
- 0.62
Bhattacharyya J, Barnes LL, Chen Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.61
Suhy J · The journal of nutrition, health & aging · 2012
- 0.61
Cummings JL, Zhong K, Ballard C et al. · International psychogeriatrics · 2025
- 0.61
Contributions of the ADNI Biostatistics Core
Beckett LA, Saito N, Donohue MC et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
- 0.61
Standardizing "Rapid": Applying the Clinical Dementia Rating to Define Rapidly Progressive Dementia
Satyadev N, Piura YD, Tipton PW et al. · Neurology · 2026
- 0.60
Lansdall CJ, Teng E, Chague J et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
- 0.60
Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network
Cummings J, Aisen P, Barton R et al. · The journal of prevention of Alzheimer's disease · 2016
- 0.60
Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans
Aisen PS, Petersen RC, Donohue M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015
- 0.59
Endpoints for trials in Alzheimer's disease: a European task force consensus
Vellas B, Andrieu S, Sampaio C et al. · The Lancet. Neurology · 2008
- 0.58
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research
Bieger A, Brum WS, Borelli WV et al. · Neurology · 2024
- 0.57
Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force
Kaye J, Aisen P, Amariglio R et al. · The journal of prevention of Alzheimer's disease · 2021
- 0.56
Shan G, Zhang Y, Wang G et al. · Statistical methods in medical research · 2025
- 0.55
Alzheimer's disease drug development: old problems require new priorities
Becker RE, Greig NH · CNS & neurological disorders drug targets · 2008
- 0.55
Growdon JH, Morris JC, Petersen RC et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
- 0.55
Kikuchi M, Adachi N, Matsumaru N et al. · Pharmaceutical medicine · 2019
- 0.55
Rockwood K, Black SE, Robillard A et al. · International journal of geriatric psychiatry · 2004
- 0.52
Errors in self-reports of health services use: impact on alzheimer disease clinical trial designs
Callahan CM, Tu W, Stump TE et al. · Alzheimer disease and associated disorders · 2015
- 0.51
PENN biomarker core of the Alzheimer's disease Neuroimaging Initiative
Shaw LM · Neuro-Signals · 2008
- 0.51
Lin Z, Sun R, Ross JS et al. · medRxiv : the preprint server for health sciences · 2025
- 0.50
Crowley P, Henry AL, Flanagan E et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.50
Power calculations for clinical trials in Alzheimer's disease
Ard MC, Edland SD · Journal of Alzheimer's disease : JAD · 2011
02pet · emission tomography45편
- 0.85
Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
Royse SK, Minhas DS, Lopresti BJ et al. · Alzheimer's research & therapy · 2021
- 0.84
Kim HJ, Kim KW, Seo SW et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
- 0.82
Chen CD, McCullough A, Gordon B et al. · European journal of nuclear medicine and molecular imaging · 2023
- 0.82
Phantom criteria for qualification of brain FDG and amyloid PET across different cameras
Ikari Y, Akamatsu G, Nishio T et al. · EJNMMI physics · 2016
- 0.81
Landau SM, Harrison TM, Baker SL et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.80
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods
Jack CRJ, Bernstein MA, Fox NC et al. · Journal of magnetic resonance imaging : JMRI · 2008
- 0.79
The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015
Jagust WJ, Landau SM, Koeppe RA et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015
- 0.78
Jack CRJ, Arani A, Borowski BJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
- 0.78
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
Jagust WJ, Bandy D, Chen K et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2010
- 0.76
Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers
Landau SM, Thomas BA, Thurfjell L et al. · European journal of nuclear medicine and molecular imaging · 2014
- 0.76
Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation
Johns E, Vossler HA, Young CB et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
- 0.75
A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research
Iaccarino L, Burnham SC, Tunali I et al. · NeuroImage. Clinical · 2025
- 0.74
Yang B, Earnest T, Kumar S et al. · Human brain mapping · 2024
- 0.74
Schmidt ME, Chiao P, Klein G et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015
- 0.74
Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer's disease
Herholz K · Biomarkers in medicine · 2012
- 0.73
Quantitative analysis of PiB-PET with FreeSurfer ROIs
Su Y, D'Angelo GM, Vlassenko AG et al. · PloS one · 2013
- 0.72
AI-enhanced Centiloid quantification of amyloid PET images
Bourgeat P, Fripp J, Lebrat L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
- 0.72
Zhang J, Soleimani-Meigooni DN, Koeppe R et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
- 0.72
Revisiting Centiloids using AI
Bourgeat P, Fripp J, Lebrat L et al. · Research square · 2025
- 0.70
Decomposition-based harmonization for quantitative PET imaging across scanners and radiotracers
Zhao S, Huang Q, Nie B et al. · Medical physics · 2026
- 0.68
Dore V, Bullich S, Rowe CC et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2019
- 0.68
Tryputsen V, DiBernardo A, Samtani M et al. · Journal of Alzheimer's disease : JAD · 2015
- 0.68
Sur C, Adamczuk K, Scott D et al. · Molecular imaging and biology · 2022
- 0.67
rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data
Iaccarino L, La Joie R, Koeppe R et al. · NeuroImage · 2022
- 0.65
Blazhenets G, Soleimani-Meigooni DN, Chiotis K et al. · JAMA · 2026
- 0.65
Automated PET tracer classification in multi-site, multi-cohort studies using deep learning
Gebre RK, Reid RI, Senjem ML et al. · EJNMMI research · 2026
- 0.65
Thurfjell L, Lilja J, Lundqvist R et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2014
- 0.64
A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease
Ruppert E, Vermeiren MR, Scop Medeiros M et al. · JAMA neurology · 2026
- 0.64
Cselenyi Z, Farde L · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2015
- 0.63
Gnorich J, Koehler M, Wind-Mark K et al. · NeuroImage · 2024
- 0.63
Lilja J, Leuzy A, Chiotis K et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
- 0.63
Osadebey ME, Pedersen M, Arnold DL et al. · BMC medical imaging · 2018
- 0.62
Presotto L, Iaccarino L, Sala A et al. · NeuroImage. Clinical · 2018
- 0.61
Chiao P, Bedell BJ, Avants B et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
- 0.61
Coupe P, Mansencal B, Morandat F et al. · Alzheimer's research & therapy · 2025
- 0.59
A Semiautomated Method for Quantification of F 18 Florbetapir PET Images
Joshi AD, Pontecorvo MJ, Lu M et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2015
- 0.58
Tonietto M, Sotolongo-Grau O, Roe-Vellve N et al. · Alzheimer's research & therapy · 2024
- 0.58
Clayton D, Coimbra A, Faraji F et al. · Neuroimage. Reports · 2021
- 0.55
Hanseeuw BJ, Malotaux V, Dricot L et al. · European journal of nuclear medicine and molecular imaging · 2021
- 0.54
A novel method for harmonization of PET image spatial resolution without phantoms
Carbonell F, Zijdenbos AP, Hempel E et al. · EJNMMI physics · 2025
- 0.54
Fleisher AS, Joshi AD, Sundell KL et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2017
- 0.53
Wang G, Li Y, Xiong C et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
- 0.52
Development and Validation of a (18)F-Flortaucipir PET Visual Stratification Method
Tunali I, Wang J, Arora AK et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
- 0.51
Athalye C, Bahena A, Khandelwal P et al. · Acta neuropathologica communications · 2025
- 0.51
Optimal Target Region for Subject Classification on the Basis of Amyloid PET Images
Carbonell F, Zijdenbos AP, Charil A et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2015
03test · scores40편
- 0.85
Weintraub S, Besser L, Dodge HH et al. · Alzheimer disease and associated disorders · 2018
- 0.80
Gauthier S, Lopez OL, Waldemar G et al. · International psychogeriatrics · 2010
- 0.79
The Alzheimer's disease activities of daily living international scale (ADL-IS)
Reisberg B, Finkel S, Overall J et al. · International psychogeriatrics · 2001
- 0.77
O'Halloran JP, Kemp AS, Salmon DP et al. · Current Alzheimer research · 2011
- 0.76
Haji B, Zhang Q, Tahami Monfared AA · The journal of prevention of Alzheimer's disease · 2025
- 0.76
Wesnes K, Edgar C, Andreasen N et al. · Acta neurologica Scandinavica · 2010
- 0.73
Coley N, Andrieu S, Jaros M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2011
- 0.73
Morris JC, Ernesto C, Schafer K et al. · Neurology · 1997
- 0.68
Hendrix S, Ellison N, Stanworth S et al. · The journal of prevention of Alzheimer's disease · 2015
- 0.68
Randolph C · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2019
- 0.67
Samara M, Levine SZ, Yoshida K et al. · Journal of Alzheimer's disease : JAD · 2021
- 0.67
Development of a straightforward and sensitive scale for MCI and early AD clinical trials
Huang Y, Ito K, Billing CBJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015
- 0.66
Jacobs DM, Thomas RG, Salmon DP et al. · Alzheimer's & dementia (New York, N. Y.) · 2020
- 0.66
Wang X, Jacobs D, Salmon DP et al. · International journal of statistics in medical research · 2023
- 0.63
Raghavan N, Samtani MN, Farnum M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013
- 0.60
Brogaard NJ, Hahn-Pedersen JH, Gundgaard J et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.60
Ard MC, Galasko DR, Edland SD · Alzheimer disease and associated disorders · 2013
- 0.60
Sachs BC, Latham LA, Isom S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.60
Doraiswamy PM, Kaiser L, Bieber F et al. · Alzheimer disease and associated disorders · 2001
- 0.59
Ueckert S, Plan EL, Ito K et al. · Pharmaceutical research · 2014
- 0.58
Schneider LS, Clark CM, Doody R et al. · Alzheimer disease and associated disorders · 2006
- 0.58
Goldberg TE, Harvey PD, Devanand DP et al. · The journal of prevention of Alzheimer's disease · 2020
- 0.58
The Feasibility of At-Home iPad Cognitive Testing For Use in Clinical Trials
Rentz DM, Dekhtyar M, Sherman J et al. · The journal of prevention of Alzheimer's disease · 2016
- 0.58
Comparison of relative change with effect size metrics in Alzheimer's disease clinical trials
Goldberg TE, Lee S, Devanand DP et al. · Journal of neurology, neurosurgery, and psychiatry · 2023
- 0.58
Thomas ML, Edland SD, Duehring J · Psychological assessment · 2026
- 0.58
Developing dementia prevention trials: baseline report of the Home-Based Assessment study
Sano M, Egelko S, Donohue M et al. · Alzheimer disease and associated disorders · 2013
- 0.57
Rutt S, Tegethoff P, Taute M et al. · European archives of psychiatry and clinical neuroscience · 2026
- 0.57
Duehring JA, Jacobs DM, Salmon DP et al. · The journal of prevention of Alzheimer's disease · 2026
- 0.56
Kiselica AM, Kaser AN, Weitzner DS et al. · Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2024
- 0.55
The preclinical Alzheimer cognitive composite: measuring amyloid-related decline
Donohue MC, Sperling RA, Salmon DP et al. · JAMA neurology · 2014
- 0.55
Potashman M, Pang M, Tahir M et al. · BMC geriatrics · 2023
- 0.55
Martin A, Meads D, Griffiths AW et al. · Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2019
- 0.54
The Alzheimer's Disease Assessment Scale
Mohs RC · International psychogeriatrics · 1996
- 0.54
Hendrix SB, Sano M, Lyketsos C et al. · International psychogeriatrics · 2025
- 0.54
Sparse item testing of clinical scales in neurology trials to alleviate burden to patients
Chen C, Novakovic A, Jamsen K et al. · Journal of neurology · 2024
- 0.54
Gillen TE, Gregg KM, Yuan H et al. · Psychopharmacology bulletin · 2001
- 0.51
Hegedus E, Pakaski M, Gosztolya G et al. · PloS one · 2024
- 0.50
Andrews JS, Desai U, Kirson NY et al. · Alzheimer's & dementia (New York, N. Y.) · 2019
- 0.50
Design of pilot studies to inform the construction of composite outcome measures
Edland SD, Ard MC, Li W et al. · Alzheimer's & dementia (New York, N. Y.) · 2017
- 0.50
ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI)
Walsh SP, Raman R, Jones KB et al. · Alzheimer disease and associated disorders · 2006
04cerebrospinal fluid · biomarkers19편
- 0.89
Wang G, Li Y, Xiong C et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.85
Timsina J, Chen Y, Liu M et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026
- 0.81
Verberk IMW, Gouda M, Antwi-Berko D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.80
Vanderstichele H, Demeyer L, Janelidze S et al. · Alzheimer's research & therapy · 2017
- 0.78
Zeng X, Chen Y, Sehrawat A et al. · Molecular neurodegeneration · 2024
- 0.77
Giangrande C, Delatour V, Andreasson U et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2023
- 0.68
Lucey BP, Gonzales C, Das U et al. · Alzheimer's research & therapy · 2015
- 0.67
Kang JH, Vanderstichele H, Trojanowski JQ et al. · Methods (San Diego, Calif.) · 2012
- 0.67
Mattsson N, Zegers I, Andreasson U et al. · Biomarkers in medicine · 2012
- 0.65
Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials
Weiner MW, Kanoria S, Miller MJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.64
Weiner MW, Veitch DP, Aisen PS et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015
- 0.64
An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels
Petzold A, Chapman MD, Schraen S et al. · Experimental neurology · 2010
- 0.62
Arneric SP, Batrla-Utermann R, Beckett L et al. · Journal of Alzheimer's disease : JAD · 2017
- 0.61
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception
Weiner MW, Veitch DP, Aisen PS et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013
- 0.59
Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer's disease
Abbas S, Ferreira PCL, Bellaver B et al. · The journal of prevention of Alzheimer's disease · 2025
- 0.59
Albert MS, DeKosky ST, Dickson D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2011
- 0.58
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception
Weiner MW, Veitch DP, Aisen PS et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2012
- 0.56
Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative
Weiner MW, Veitch DP · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015
- 0.51
Garbarino VR, Palavicini JP, Melendez J et al. · Research square · 2024
05intervention · randomized5편
- 0.88
Clinical Data Interchange Standards in Clinical Trials on Alzheimer's Disease 이 논문
Na R, Bae JB, Jung SH et al. · Psychiatry investigation · 2022
- 0.60
Impacts of informant replacement in two industry-sponsored Alzheimer's disease clinical trials
Nishida MK, Nuno MM, Grill JD et al. · Alzheimer's & dementia (New York, N. Y.) · 2024
- 0.59
ADCS Prevention Instrument Project: overview and initial results
Ferris SH, Aisen PS, Cummings J et al. · Alzheimer disease and associated disorders · 2006
- 0.58
Current Alzheimer's disease clinical trials: methods and placebo outcomes
Schneider LS, Sano M · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2009
- 0.52
Determining the minimum clinically important differences for outcomes in the DOMINO trial
Howard R, Phillips P, Johnson T et al. · International journal of geriatric psychiatry · 2011
06imaging · brain5편
- 0.80
Simmons A, Westman E, Muehlboeck S et al. · International journal of geriatric psychiatry · 2011
- 0.68
Japanese Alzheimer's Disease Neuroimaging Initiative: present status and future
Iwatsubo T · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2010
- 0.68
Kapoor A, Bartha R, Black SE et al. · Journal of Alzheimer's disease : JAD · 2020
- 0.55
Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease
Teipel SJ, Grothe M, Lista S et al. · The Medical clinics of North America · 2013
- 0.51
Characterizing amyloid and tau PET-based stages across the clinical continuum
Cody KA, Sokolowski A, Johns E et al. · medRxiv : the preprint server for health sciences · 2025
07review · therapeutic5편
- 0.72
Schwarz AJ · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
- 0.72
European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND)
Duzel E, Acosta-Cabronero J, Berron D et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2019
- 0.59
Stephenson D, Aviles E, Bain LJ et al. · Therapeutic innovation & regulatory science · 2013
- 0.54
Sperling RA, Jack CRJ, Black SE et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2011
- 0.51
Liu Y, Fowler H, Wang DD et al. · Nutrients · 2025
08review · meta-analysis2편
- 0.72
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review
Christa Maree Stephan B, Minett T, Pagett E et al. · BMJ open · 2013
- 0.71
Yang F, Dawes P, Leroi I et al. · International journal of geriatric psychiatry · 2018